Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M. Younossi, Victor Ankoma‐Sey, Susanne Beckebaum et al.|The Lancet|2019Cited by 1.2k
Sirolimus Use in Liver Transplant Recipients With Hepatocellular CarcinomaEdward K. Geissler, Raimund Margreiter, Andreas A. Schnitzbauer et al.|Transplantation|2015Cited by 417
A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECTLutz Fischer, Hans J. Schlitt, J. Klempnauer et al.|American Journal of Transplantation|2012Cited by 189
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasionQingli Shen, Susanne Beckebaum|Molecular Cancer|2010Cited by 180